Evidence map›Paper›PMID 24828204›Full record

ArticleInternational journal of molecular sciences2014

Inhibitory effects of palmultang on inflammatory mediator production related to suppression of NF-κB and MAPK pathways and induction of HO-1 expression in macrophages.

You-Chang Oh, Yun Hee Jeong, Won-Kyung Cho, Min-Jung Gu, Jin Yeul Ma

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Frontiers in pharmacology · 2021
    Article
  3. Article
  4. Beneficial Effects of Gagam-Palmultang on Scopolamine-Induced Memory Deficits in Mice.Evidence-based complementary and alternative medicine : eCAM · 2018
    Article
  5. Article
  6. Molecular science for drug development and biomedicine.International journal of molecular sciences · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

You-Chang OhKorean Medicine (KM)-Based Herbal Drug Development Group, Korea Institute of Oriental Medicine, 461-24, Jeonmin-dong, Yuseong, Daejeon 305-811, Korea. ulivuli@kiom.re.kr.
Yun Hee JeongKorean Medicine (KM)-Based Herbal Drug Development Group, Korea Institute of Oriental Medicine, 461-24, Jeonmin-dong, Yuseong, Daejeon 305-811, Korea. runxi0333@kiom.re.kr.
Won-Kyung ChoKorean Medicine (KM)-Based Herbal Drug Development Group, Korea Institute of Oriental Medicine, 461-24, Jeonmin-dong, Yuseong, Daejeon 305-811, Korea. wkcho@kiom.re.kr.
Min-Jung GuKorean Medicine (KM)-Based Herbal Drug Development Group, Korea Institute of Oriental Medicine, 461-24, Jeonmin-dong, Yuseong, Daejeon 305-811, Korea. guminjung@kiom.re.kr.
Jin Yeul MaKorean Medicine (KM)-Based Herbal Drug Development Group, Korea Institute of Oriental Medicine, 461-24, Jeonmin-dong, Yuseong, Daejeon 305-811, Korea. jyma@kiom.re.kr.
Korea Institute of Oriental Medicine · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Palmultang (PM) is an herbal decoction that has been used to treat anorexia, anemia, general prostration, and weakness due to chronic illness since medieval times in Korea, China, and Japan. The present study focused on the inhibitory effects of PM on the production of inflammatory factors and on the activation of mechanisms in murine macrophages. PM suppressed the expression of nitric oxide (NO), inflammatory cytokines and inflammatory proteins by inhibiting nuclear factor (NF)-κB and mitogen-activated protein kinase (MAPK) signaling pathways and by inducing heme oxygenase (HO)-1 expression. Collectively, our results explain the anti-inflammatory effect and inhibitory mechanism of PM in macrophages stimulated with lipopolysaccharide (LPS).

Indexed as

AnimalsAnti-Inflammatory AgentsCell LineCell SurvivalHeme Oxygenase-1Inflammation MediatorsLipopolysaccharidesMacrophagesMiceMitogen-Activated Protein KinasesNF-kappa BNitric Oxide Synthase Type IIPhosphorylationPlant ExtractsPlants, MedicinalSignal TransductionAnti-Inflammatory AgentsHeme Oxygenase-1Inflammation MediatorsLipopolysaccharidesMitogen-Activated Protein KinasesNF-kappa BNitric Oxide Synthase Type IIPlant Extracts

Identifiers

PMID24828204
PMCPMC4057741
OpenAlexW2040232194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.